Insulet reports 21% sales growth in Q1, raises 2023 guidance

Insulet (Nasdaq:PODD) shares ticked up after hours today on first-quarter results that topped the consensus forecast.

Related Keywords

Acton ,Massachusetts ,United States ,Jim Hollingshead ,Massdevice Medtech , ,Total Omnipod ,Wall Street ,